Understanding Secondary HLH/MAS
Hemophagocytic lymphohistiocytosis / macrophage activation syndrome (HLH/MAS) is a rare and severe disease associated with high mortality rates. This Learning Zone will provide resources to help you recall key features of secondary HLH/MAS, overcome diagnostic challenges, and select the right treatment for your patients.
Check in here over the next 12 months to:
- Recall the clinical features of this rare disease as well as the impact of delayed diagnosis on patient outcomes
- Review guideline recommendations and hear expert advice on the early diagnosis of secondary HLH/MAS and how to select the right treatment approach
- Find out more about the role of biomarkers in disease management, from diagnosis to disease monitoring
- View case study examples of differential diagnosis, to help you navigate complex treatment selection and apply the latest guidance to your clinical practice
HLH/MAS: A multifaceted syndrome
Read an overview of secondary HLH/MAS, a rare and severe syndrome, and learn about the recommended diagnostic algorithm and treatment approaches.
Developed independently by EPG Health, which received an educational grant from Sobi, awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event